Telemedicine with special focus on allergic diseases and asthma-Status 2022 : An EAACI position paper
© 2023 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd..
Efficacious, effective and efficient communication between healthcare professionals (HCP) and patients is essential to achieve a successful therapeutic alliance. Telemedicine (TM) has been used for decades but during the COVID-19 pandemic its use has become widespread. This position paper aims to describe the terminology and most important forms of TM among HCP and patients and review the existing studies on the uses of TM for asthma and allergy. Besides, the advantages and risks of TM are discussed, concluding that TM application reduces costs and time for both, HCP and patients, but cannot completely replace face-to-face visits for physical examinations and certain tests that are critical in asthma and allergy. From an ethical point of view, it is important to identify those involved in the TM process, ensure confidentiality and use communication channels that fully guarantee the security of the information. Unmet needs and directions for the future regarding implementation, data protection, privacy regulations, methodology and efficacy are described.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:79 |
|---|---|
| Enthalten in: |
Allergy - 79(2024), 4 vom: 01. Apr., Seite 777-792 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Smolinska, Sylwia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
E‐health |
|---|
| Anmerkungen: |
Date Completed 01.04.2024 Date Revised 01.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/all.15964 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365324191 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365324191 | ||
| 003 | DE-627 | ||
| 005 | 20240401232427.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/all.15964 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1359.xml |
| 035 | |a (DE-627)NLM365324191 | ||
| 035 | |a (NLM)38041429 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Smolinska, Sylwia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Telemedicine with special focus on allergic diseases and asthma-Status 2022 |b An EAACI position paper |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.04.2024 | ||
| 500 | |a Date Revised 01.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. | ||
| 520 | |a Efficacious, effective and efficient communication between healthcare professionals (HCP) and patients is essential to achieve a successful therapeutic alliance. Telemedicine (TM) has been used for decades but during the COVID-19 pandemic its use has become widespread. This position paper aims to describe the terminology and most important forms of TM among HCP and patients and review the existing studies on the uses of TM for asthma and allergy. Besides, the advantages and risks of TM are discussed, concluding that TM application reduces costs and time for both, HCP and patients, but cannot completely replace face-to-face visits for physical examinations and certain tests that are critical in asthma and allergy. From an ethical point of view, it is important to identify those involved in the TM process, ensure confidentiality and use communication channels that fully guarantee the security of the information. Unmet needs and directions for the future regarding implementation, data protection, privacy regulations, methodology and efficacy are described | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a e‐health | |
| 650 | 4 | |a m‐health | |
| 650 | 4 | |a telecare | |
| 650 | 4 | |a telehealth | |
| 650 | 4 | |a telemedicine | |
| 700 | 1 | |a Popescu, Florin-Dan |e verfasserin |4 aut | |
| 700 | 1 | |a Izquierdo, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Antolín-Amérigo, Darío |e verfasserin |4 aut | |
| 700 | 1 | |a Price, Oliver J |e verfasserin |4 aut | |
| 700 | 1 | |a Alvarez-Perea, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Eguíluz Gracia, Ibon |e verfasserin |4 aut | |
| 700 | 1 | |a Papadopoulos, Nikolaos G |e verfasserin |4 aut | |
| 700 | 1 | |a Pfaar, Oliver |e verfasserin |4 aut | |
| 700 | 1 | |a Fassio, Filippo |e verfasserin |4 aut | |
| 700 | 1 | |a Hoffmann-Sommergruber, Karin |e verfasserin |4 aut | |
| 700 | 1 | |a Dramburg, Stephanie |e verfasserin |4 aut | |
| 700 | 1 | |a Agache, Ioana |e verfasserin |4 aut | |
| 700 | 1 | |a Jutel, Marek |e verfasserin |4 aut | |
| 700 | 1 | |a Brough, Helen A |e verfasserin |4 aut | |
| 700 | 1 | |a Fonseca, João A |e verfasserin |4 aut | |
| 700 | 1 | |a Angier, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Boccabella, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Bonini, Matteo |e verfasserin |4 aut | |
| 700 | 1 | |a Dunn Galvin, Audrey |e verfasserin |4 aut | |
| 700 | 1 | |a Gibson, Peter G |e verfasserin |4 aut | |
| 700 | 1 | |a Gawlik, Radoslaw |e verfasserin |4 aut | |
| 700 | 1 | |a Hannachi, Farah |e verfasserin |4 aut | |
| 700 | 1 | |a Kalayci, Ömer |e verfasserin |4 aut | |
| 700 | 1 | |a Klimek, Ludger |e verfasserin |4 aut | |
| 700 | 1 | |a Knibb, Rebecca |e verfasserin |4 aut | |
| 700 | 1 | |a Matricardi, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Chivato, Tomás |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Allergy |d 1980 |g 79(2024), 4 vom: 01. Apr., Seite 777-792 |w (DE-627)NLM000313874 |x 1398-9995 |7 nnns |
| 773 | 1 | 8 | |g volume:79 |g year:2024 |g number:4 |g day:01 |g month:04 |g pages:777-792 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/all.15964 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 79 |j 2024 |e 4 |b 01 |c 04 |h 777-792 | ||